BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1767552)

  • 1. [Prevention, inclusion and therapy of congenital toxoplasmosis in the Basel region (Switzerland)].
    Berger R; Fernex M; Just M; Rudin C; Stürchler D
    Z Arztl Fortbild (Jena); 1991 Nov; 85(22):1103-5. PubMed ID: 1767552
    [No Abstract]   [Full Text] [Related]  

  • 2. [Toxoplasmosis and pregnancy--findings from umbilical cord blood screening in 30,000 newborn infants].
    Berger R; Merkel S; Rudin C
    Schweiz Med Wochenschr; 1995 Jun; 125(23):1168-73. PubMed ID: 7597405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preventive studies of congenital toxoplasmosis based on studies conducted in other countries].
    Rydzewski A
    Wiad Parazytol; 1988; 34(4-6):713-8. PubMed ID: 3242304
    [No Abstract]   [Full Text] [Related]  

  • 4. [Why monitor infants born to mothers who had a seroconversion for toxoplasmosis during pregnancy? Reality and risk of subclinical congenital toxoplasmosis in children. Review of 30,768 births].
    Philippe F; Lepetit D; Grancher MF; Morel A; Henocq A
    Ann Pediatr (Paris); 1988 Jan; 35(1):5-10. PubMed ID: 3364907
    [No Abstract]   [Full Text] [Related]  

  • 5. [15 years of toxoplasmosis surveillance of pregnant women in Austria. An exemplary results in the prevention of neonatal infection].
    Aspöck H; Flamm H
    Osterr Krankenpflegez; 1990; 43(8-9):252-3. PubMed ID: 2234953
    [No Abstract]   [Full Text] [Related]  

  • 6. Cord blood screening for congenital toxoplasmosis in northwestern Switzerland, 1982-1999.
    Signorell LM; Seitz D; Merkel S; Berger R; Rudin C
    Pediatr Infect Dis J; 2006 Feb; 25(2):123-8. PubMed ID: 16462288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of primary prevention on the incidence of toxoplasmosis during pregnancy.
    Foulon W; Naessens A; Lauwers S; De Meuter F; Amy JJ
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):363-6. PubMed ID: 3405553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of toxoplasmosis: observations on follow-up experience in France].
    Desmonts G
    Prog Clin Biol Res; 1985; 163B():333-7. PubMed ID: 3983162
    [No Abstract]   [Full Text] [Related]  

  • 9. [20 years of screening for toxoplasmosis in pregnant women. The Liège experience in 20,000 pregnancies].
    Horion M; Thoumsin H; Senterre J; Lambotte R
    Rev Med Liege; 1990 Oct; 45(10):492-7. PubMed ID: 2255826
    [No Abstract]   [Full Text] [Related]  

  • 10. [Epidemiology and prevention of toxoplasmosis].
    Dzbeński TH; Kopaczowa G
    Przegl Epidemiol; 1984; 38(2):235-41. PubMed ID: 6505244
    [No Abstract]   [Full Text] [Related]  

  • 11. [Occurrence of toxoplasmosis in pregnant women in Denmark. A study of 5.402 pregnant women].
    Lebech M; Larsen SO; Petersen E
    Ugeskr Laeger; 1995 Sep; 157(38):5242-5. PubMed ID: 7483039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Toxoplasma infestation: prevalence, risk of congenital infection and development in Geneva from 1973 to 1987].
    Bornand JE; Piguet JD
    Schweiz Med Wochenschr; 1991 Jan; 121(1-2):21-9. PubMed ID: 1990419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of a toxoplasmosis screening].
    Mayer HO; Stünzner D; Rosanelli K
    Zentralbl Gynakol; 1983; 105(17):1097-100. PubMed ID: 6359783
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prospective seroepidemiological study for the determination of the incidence of congenital toxoplasmosis].
    Mária J; Endre C; Róbert V
    Orv Hetil; 1978 May; 119(21):1275-80. PubMed ID: 565910
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prevention of congenital toxoplasmosis in France. Risk assessment. Results and perspectives of prenatal screening and newborn follow up].
    Ambroise-Thomas P; Schweitzer M; Pinon JM; Thiebaugeorges O
    Bull Acad Natl Med; 2001; 185(4):665-83; discussion 684-8. PubMed ID: 11503357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Congenital toxoplasmosis with delayed immune response].
    Bruns R; Wiersbitzky S; Rintala T; Wiersbitzky H
    Zentralbl Gynakol; 1989; 111(13):925-9. PubMed ID: 2800777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Theoretical bases of the prevention by spiramycin of congenital toxoplasmosis in pregnant women].
    Garin JP; Pellerat J; Maillard ; Woehrle R; Hezez
    Presse Med (1893); 1968 Dec; 76(48):2266. PubMed ID: 5720932
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnosis of congenital toxoplasmosis: pre- and post-natal evaluation in Sicilian (Italy) epidemiological area. Preliminary data.
    Di Carlo P; Casuccio A; La Chiusa S; Mazzola A; Pampinella D; Romano A; Schimmenti MG; Titone L; Mancuso G
    Parassitologia; 2007 Jun; 49(1-2):39-41. PubMed ID: 18416004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of congenital toxoplasmosis].
    Koppe JG
    Ned Tijdschr Geneeskd; 1992 Aug; 136(31):1501-4. PubMed ID: 1495566
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention of congenital toxoplasmosis].
    Verbrugge HP
    Ned Tijdschr Geneeskd; 1988 Jul; 132(28):1303. PubMed ID: 3405330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.